Iron supplements reduce erythrocyte copper-zinc superoxide dismutase activity in term, breastfed infants

Magnus Domellöf, Kathryn Dewey, Roberta Cohen, Bo Lönnerdal, Olle Hernell

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Aim: To investigate whether iron supplements compromise copper status in infants. Methods: 214 healthy, term, breastfed Swedish and Honduran infants were randomized to (1) iron supplements (1 mg/kg/d) from 4-9 mo of age, (2) iron supplements from 6-9 mo, or (3) placebo. Blood samples were obtained at 4, 6, and 9 mo and analyzed for plasma copper (p-Cu) and, at 9 mo, for copper/zinc-dependent superoxide dismutase (CuZn-SOD) activity. Results: P-Cu increased with infant age. At 9 mo, Honduran infants had significantly higher p-Cu (1.40±0.29 vs 1.09±0.22 mg/l, p Conclusion: There is a physiologic increase in p-Cu during the first 9 mo of life. Differences in copper status between Swedish and Honduran infants may be due to genetic or nutritional differences. Iron supplementation decreases CuZn-SOD activity, probably due to a negative effect on copper status. Possible clinical implications remain to be elucidated.

Original languageEnglish (US)
Pages (from-to)1578-1582
Number of pages5
JournalActa Paediatrica, International Journal of Paediatrics
Volume94
Issue number11
DOIs
StatePublished - Nov 2005

Fingerprint

Superoxide Dismutase
Zinc
Copper
Iron
Erythrocytes
Nutrigenomics
Placebos

Keywords

  • Copper
  • Infant
  • Iron
  • Superoxide dismutase
  • Supplements

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Iron supplements reduce erythrocyte copper-zinc superoxide dismutase activity in term, breastfed infants. / Domellöf, Magnus; Dewey, Kathryn; Cohen, Roberta; Lönnerdal, Bo; Hernell, Olle.

In: Acta Paediatrica, International Journal of Paediatrics, Vol. 94, No. 11, 11.2005, p. 1578-1582.

Research output: Contribution to journalArticle

Domellöf, Magnus ; Dewey, Kathryn ; Cohen, Roberta ; Lönnerdal, Bo ; Hernell, Olle. / Iron supplements reduce erythrocyte copper-zinc superoxide dismutase activity in term, breastfed infants. In: Acta Paediatrica, International Journal of Paediatrics. 2005 ; Vol. 94, No. 11. pp. 1578-1582.
@article{98167b7fceb8453da10ca21db4b891d8,
title = "Iron supplements reduce erythrocyte copper-zinc superoxide dismutase activity in term, breastfed infants",
abstract = "Aim: To investigate whether iron supplements compromise copper status in infants. Methods: 214 healthy, term, breastfed Swedish and Honduran infants were randomized to (1) iron supplements (1 mg/kg/d) from 4-9 mo of age, (2) iron supplements from 6-9 mo, or (3) placebo. Blood samples were obtained at 4, 6, and 9 mo and analyzed for plasma copper (p-Cu) and, at 9 mo, for copper/zinc-dependent superoxide dismutase (CuZn-SOD) activity. Results: P-Cu increased with infant age. At 9 mo, Honduran infants had significantly higher p-Cu (1.40±0.29 vs 1.09±0.22 mg/l, p Conclusion: There is a physiologic increase in p-Cu during the first 9 mo of life. Differences in copper status between Swedish and Honduran infants may be due to genetic or nutritional differences. Iron supplementation decreases CuZn-SOD activity, probably due to a negative effect on copper status. Possible clinical implications remain to be elucidated.",
keywords = "Copper, Infant, Iron, Superoxide dismutase, Supplements",
author = "Magnus Domell{\"o}f and Kathryn Dewey and Roberta Cohen and Bo L{\"o}nnerdal and Olle Hernell",
year = "2005",
month = "11",
doi = "10.1080/08035250500252674",
language = "English (US)",
volume = "94",
pages = "1578--1582",
journal = "Acta Paediatrica, International Journal of Paediatrics",
issn = "0803-5253",
publisher = "Wiley-Blackwell",
number = "11",

}

TY - JOUR

T1 - Iron supplements reduce erythrocyte copper-zinc superoxide dismutase activity in term, breastfed infants

AU - Domellöf, Magnus

AU - Dewey, Kathryn

AU - Cohen, Roberta

AU - Lönnerdal, Bo

AU - Hernell, Olle

PY - 2005/11

Y1 - 2005/11

N2 - Aim: To investigate whether iron supplements compromise copper status in infants. Methods: 214 healthy, term, breastfed Swedish and Honduran infants were randomized to (1) iron supplements (1 mg/kg/d) from 4-9 mo of age, (2) iron supplements from 6-9 mo, or (3) placebo. Blood samples were obtained at 4, 6, and 9 mo and analyzed for plasma copper (p-Cu) and, at 9 mo, for copper/zinc-dependent superoxide dismutase (CuZn-SOD) activity. Results: P-Cu increased with infant age. At 9 mo, Honduran infants had significantly higher p-Cu (1.40±0.29 vs 1.09±0.22 mg/l, p Conclusion: There is a physiologic increase in p-Cu during the first 9 mo of life. Differences in copper status between Swedish and Honduran infants may be due to genetic or nutritional differences. Iron supplementation decreases CuZn-SOD activity, probably due to a negative effect on copper status. Possible clinical implications remain to be elucidated.

AB - Aim: To investigate whether iron supplements compromise copper status in infants. Methods: 214 healthy, term, breastfed Swedish and Honduran infants were randomized to (1) iron supplements (1 mg/kg/d) from 4-9 mo of age, (2) iron supplements from 6-9 mo, or (3) placebo. Blood samples were obtained at 4, 6, and 9 mo and analyzed for plasma copper (p-Cu) and, at 9 mo, for copper/zinc-dependent superoxide dismutase (CuZn-SOD) activity. Results: P-Cu increased with infant age. At 9 mo, Honduran infants had significantly higher p-Cu (1.40±0.29 vs 1.09±0.22 mg/l, p Conclusion: There is a physiologic increase in p-Cu during the first 9 mo of life. Differences in copper status between Swedish and Honduran infants may be due to genetic or nutritional differences. Iron supplementation decreases CuZn-SOD activity, probably due to a negative effect on copper status. Possible clinical implications remain to be elucidated.

KW - Copper

KW - Infant

KW - Iron

KW - Superoxide dismutase

KW - Supplements

UR - http://www.scopus.com/inward/record.url?scp=28744436459&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=28744436459&partnerID=8YFLogxK

U2 - 10.1080/08035250500252674

DO - 10.1080/08035250500252674

M3 - Article

VL - 94

SP - 1578

EP - 1582

JO - Acta Paediatrica, International Journal of Paediatrics

JF - Acta Paediatrica, International Journal of Paediatrics

SN - 0803-5253

IS - 11

ER -